Journals / Gazi Medical Journal / 2017 / Cilt: 28 - Sayı: 2

The Effect of Picroside-2 on Erythrocyte Deformability and Lipid Peroxidation in StreptozotocinInduced Diabetic Rats Subjected to Left Anterior Descending Artery-Ischaemia Reperfusion

Pages
98–101
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Serum malondialdehyde andnitric oxide activities were investigated to document lipid peroxidation anderythrocyte deformability index.Results: Deformability index was notably increased in diabetic rats (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Diabetes mellitus (DM) is a chronic metabolic disorder principallycharacterized by an elevation in oxidative stress levels.
📊
Key Findings & Data:Recent studies have found thatpicroside-2 has antioxidant, neuroprotective and anti-inflamatory effects.
💡
Conclusion & Impact:Serum malondialdehyde andnitric oxide activities were investigated to document lipid peroxidation anderythrocyte deformability index.Results: Deformability index was notably increased in diabetic rats (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Diabetes mellitus (DM) is a chronic metabolic disorder principallycharacterized by an elevation in oxidative stress levels. Ischaemia-reperfusion(IR) injury starts a cascade of events that lead to tissue ischaemia and cellulardamage produced by reperfusion causing an inflammatory like response. Erythrocyte deformability and plasma viscosity are important clinicalimplications for organ and tissue perfusion. Recent studies have found thatpicroside-2 has antioxidant, neuroprotective and anti-inflamatory effects. Theaim of our study was to investigate the effects of picroside-2 on erythrocytedeformability and lipid peroxidation in streptozotocin-induced diabetic ratssubjected to left anterior descending (LAD) artery IR.Methods: The animals were randomly assigned to one of five experimentalgroups. In Group (control) C, DC (diabetes-control group), and DP (diabetespicroside-2group) neither coronary artery occlusion nor reperfusion wereperformed in the control rats. In Group DIR, a branch of the LAD artery wasoccluded for 45 minutes followed by 90 minutes of reperfusion to produce IR.In Group DIRP, picroside-2 was administrated via 10 mg.kg-1 inraperitoneal (IP)route 30 minutes before ligating the LAD artery. Serum malondialdehyde andnitric oxide activities were investigated to document lipid peroxidation anderythrocyte deformability index.Results: Deformability index was notably increased in diabetic rats (p

Özet

Amaç: Diyabetes mellitus (DM), özellikle oksidatif stres seviyelerinde yükselme ile karakterize edilen kronik bir metabolik bozukluktur. İskemi-reperfüzyon (İR) hasarı, doku iskemisi ve reperfüzyonla üretilen hücresel hasara yol açan, bir dizi inflamatuar cevap benzeri olay sonucunda başlar. Eritrosit deformabilitesi ve plazma viskozitesi, organ ve doku perfüzyonu için önemli klinik belirteçlerdir. Son yıllardaki araştırmalar, pikrozid-2'nin antioksidan, nöroprotektif ve antiinflamatuar etkilere sahip olduğunu bulmuştur. Çalışmamızın amacı, streptozosin ile diyabet oluşturulan, sol ön inen (LAD) arter için İR uygulanan ratlarda pikrozid-2'nin eritrosit deformabilitesi ve lipid peroksidasyonu üzerine etkilerini araştırmaktı. Yöntem: Hayvanlar rasgele beş gruba ayrıldı. Grup K, DK (diyabet kontrol grubu) ve DP (diyabet-pikrozid-2 grubu) ratlarında koroner arter oklüzyonu veya reperfüzyon uygulanmadı. Grup DİR'de LAD arterinin bir dalı 45 dakika boyunca kapatıldı, bunu takiben İR hasarına neden olmak için 90 dakika reperfüzyon uygulandı. Grup DİRP'de LAD arterinin bağlanmasından 30 dakika önce 10 mg.kg-1 intraperitoneal (IP) yolu ile pikrozid-2 uygulandı. Serum malondialdehit ve nitrik oksit aktiviteleri, lipid peroksidasyonu ve eritrosit deformabilite indeksi değerlendirildi. Bulgular: Deformabilite indeksi diyabetik ratlarda belirgin şekilde arttı (p

🔖

Cite This Article

DURSUN, A. D., ARSLAN, M., KÜÇÜK, A., ÇOMU, F. M., ERER, D., ÖZER, A., BOYUNAĞA, H., TATAR, T., POLAT, Y., KİRİŞÇİ, M., KARTAL, H. (2022). The Effect of Picroside-2 on Erythrocyte Deformability and Lipid Peroxidation in StreptozotocinInduced Diabetic Rats Subjected to Left Anterior Descending Artery-Ischaemia Reperfusion. Gazi Medical Journal, Cilt: 28 - Sayı: 2, 98–101. https://ajindex.com/articles/519858

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Robertshaw HJ, Hall GM. Diabetes mellitus: anaesthetic management. Anaesthesia 2010;61: 1187-90.
  2. McAnulty GR, Robertshaw HJ, Hall GM. Anaesthetic management of patients with diabetes mellitus. Br J Anesth 2000; 85: 80-90.
  3. McAnulty GR, Hall GM. Anaesthesia for the diabetic patient. Br J Anesth 2003; 88: 428-30.
  4. Gu W, Pagel PS, Warltier DC, Kersten JR. Modifying cardiovascular risks in diabetes mellitus. Anesthesiology 2003;98: 774-9.
  5. Giquel J, Rodriguez-Blanco YF, Matadial C, Candiotti K. Diabetes mellitus in anaesthesia. Br J Diabetes Vasc Dis 2012;12: 60-4. Miller RD. Miller’s Anesthesia. 7th ed. In: Roizen MF, Fleisher LA, eds. Anesthesia implications of current disease. Chicago: Year Book Medical Publishers, 2010:1067-149. Kadoi Y. Anesthetic considerations in diabetic patients. Part I: preoperative considerations of patients with diabetes mellitus. J Anesth 2010; 24: 739-47.
  6. Margolis JR, Kannel WS, Feinleib M, Dawber TR, McNamara PM. Clinical features of unrecognized myocardial infarction silent and symptomatic. Eighteen year follow-up: Framingham study. Am J Cardiol 1973;32: 1-7.
  7. Peto K, Nemeth N, Brath E, Takacs IE, Baskurt OK, Meiselman HJ, et al. The effects of renal ischemia-reperfusion on hemorheological factors: preventive role of allopurinol. Clin Hemorheol Microcirc 2007; 37: 347-58.
  8. Vincent AM, Russell JW, Low P, Feldman EL.Oxidative stress in the pathogenesis of diabetic neuropathy. Endocrine Reviews 2004; 25: 612–28.
  9. Memisogullari R, Taysi S, Bakan E, Capoglu I. Antioxidant status and lipid peroxidation in Type II Diabetes Mellitus. Cell Biochem Func 2003; 21: 291-6. Sacks DB. Diabetes Mellitus. In: Burtis CA, Ashwood ER, (Ed). Tietz Texbook of clinical chemistry. Philadelphia: WB Saunders Co: 1999; pp 766-76.
  10. Cherubini A, Ruggiero C, Polidori MC, Mecocci C. Potential markers of oxidative stress in stroke. Free Radic Biol Med 2005;39: 841-52.
  11. Memişoğulları R, Bakan E. Levels of ceruloplasmin, transferrin, and lipid peroxidation in the serum of patients with Type 2 diabetes mellitus. J Diabetes Complications 2004;18: 193-7.
  12. Masella R, Benedetto RD, Varý R, Filesi C, Giovannini C. Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathionerelated enzymes. J Nutr Biochem 2005;16: 577–86. Das UN. Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction. Mol Cell Biochem 2000;215(1-2):145-52.
  13. Cho YI, Mooney MP, Cho DJ. Hemorheological disorders in diabetes mell